The GOALPOST Trial builds on the findings of CHAP and Sinkey’s preliminary clinical trial, called the ACHIEVE Trial, which is ...
Tamara Murdock, global head of early phase at Emerald Clinical Trials emphasises the importance for sponsors in choosing the ...
24mon MSNOpinion
Misapplied pharmaceutical model prevents scaling of effective interventions, researcher argues
A new article published in the Journal of Medical Internet Research challenges the foundational research model that has ...
Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, ...
A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, ...
GlobalData on MSN
Multiple sclerosis: three trials to watch
"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
PsyPost on MSN
“Major problem”: Ketamine fails to outperform placebo for treating severe depression in new clinical trial
A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients ...
Chicago's Lurie Children's Hospital this week launched a new advanced leukemia program.
HealthDay on MSN
Clinical Trial Finds Ketamine Not Effective For Depression
Key Takeaways Ketamine isn’t effective in treating depression, new clinical trial results indicateKetamine did not provide ...
The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the ...
AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy ...
On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback